EP1713796A1 - Process for preparing substituted benzopyran compounds - Google Patents

Process for preparing substituted benzopyran compounds

Info

Publication number
EP1713796A1
EP1713796A1 EP05726439A EP05726439A EP1713796A1 EP 1713796 A1 EP1713796 A1 EP 1713796A1 EP 05726439 A EP05726439 A EP 05726439A EP 05726439 A EP05726439 A EP 05726439A EP 1713796 A1 EP1713796 A1 EP 1713796A1
Authority
EP
European Patent Office
Prior art keywords
group
compound
following formula
solvates
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05726439A
Other languages
German (de)
French (fr)
Other versions
EP1713796A4 (en
Inventor
Nam Kyu Lee
Ju Young Lee
Jae-Sun Kim
Jae Yoon Jung
Key An Um
Yong Ho Oh
Ho Chul Shin
Woo Jae Jang
Guang-Jin Im
Tae Kon A Laboratory of SK Chemicals Co. Ltd KIM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SK Chemicals Co Ltd
Original Assignee
SK Chemicals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SK Chemicals Co Ltd filed Critical SK Chemicals Co Ltd
Publication of EP1713796A1 publication Critical patent/EP1713796A1/en
Publication of EP1713796A4 publication Critical patent/EP1713796A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the present invention relates to a novel method of preparing substituted benzopyran compounds of the following formula 1, their corresponding novel intermediates and a method of their preparation thereof.
  • a benzopyran compound is a leukotriene-receptor antagonist already disclosed in EP 0173516 and others, which is also known as a therapeutic agent for treating diseases induced by leukotriene and 5- ⁇ -reductase.
  • JP Hei 3- 95144 discloses a method of preparing 3-amino-2-hydroxyacetophenone from the phenol compound of the following formula (A) via a four step process.
  • this method is not considered efficient due to its rather long process and also it lacks industrial applicability due to the risk of explosion during a hydrogenation reaction using Pd/C in the reduction step (a) for introducing an amino group.
  • X indicates a halogen atom.
  • This invention relates to a method of synthesizing a few novel benzopyran compounds disclosed in EP 0173516.
  • the method of the present invention is industrially more applicable since it provides an added safety and efficiency with a fewer number of steps in process as compared to the conventional methods.
  • the method of this invention follows the convergent pathway, a more efficient process than the conventional linear process.
  • the method of the present invention does not employ a risky process such as hydrogenation reaction and the intermediate materials produced during the reaction are so stable that their separation and purification are quite easy.
  • This invention relates to a method of preparing substituted benzopyran compounds having the chemical structure of the following formula 1, a novel intermediate compound used for the process thereof, and a method of preparing the intermediate compound.
  • R 1 is selected from the group consisting of a Q-2o alkyl group, a C2-20 alkenyl group, a C2-20 alkynyl group, a phenyl group, a naphthalenyl group and an indanyl group, wherein the groups can be independently substituted by 1 or 2 substituents selected from a C ⁇ -2 o alkyl group, a C 2-2 o alkenyl group and a C 2-2 o alkynyl group, wherein up to 5 carbon atoms of the substitution groups can be selectively substituted by O, S, N, a halogen atom, a benzene ring, a thiophene ring, a naphthalene ring, a C4-7 carbocyclic ring, a carbonyl group, a carbonyloxy group, a hydroxyl group, a carboxy group, an azido group or a nitro group; R 2 and R 4 are independently
  • R 1 is a phenyl group or a substituted phenyl group, wherein the above substituted phenyl group can be substituted with 1 or 2 substituents selected from a C1-20 alkyl group, a C2-20 alkenyl group and a C2-20 alkynyl group, wherein up to 5 carbon atoms of the substitution groups can be selectively substituted by O, S, N, a halogen atom, a benzene ring, a thiophene ring, a naphthalene ring, a C -7 carbocyclic ring, a carbonyl group, a carbonyloxy group, a hydroxyl group, a carboxy group, an azido group or a nitro group.
  • R 1 is a phenyl group substituted at p-position with a substituent from those exemplified above, and more preferably
  • R 2 and R 4 are independently H, a Ci-6 alkyl group, a C2-6 alkenyl group, a Ci-6 alkyl group substituted with from 1 to 3 aryl groups, or a Ci-6 alkoxycarbonyl group. More preferably, R 2 and R 4 are independently H.
  • R 3 is H. In preparing the substituted benzopyran compounds of the above formula 1,
  • A is a single bond; or a methylene, ethylene, trimethylene, tetramethylene, vinylene, propenylene, butenylene, butadienylene or ethynylene group either substituted or unsubstituted with from 1 to 3 substituents selected from a C ⁇ -10 alkyl group and a phenyl group. More preferably, A is a single bond.
  • the substituted benzopyran compounds of the above formula 1 according to the present invention can be prepared by reacting a compound of the following formula 2 with a compound of the following formula 3 as shown in the following reaction scheme 1.
  • reaction Scheme 1 In the above reaction scheme 1, R 1 , R 2 , R 3 , R 4 , A, X and Y are the same as defined in the above formula 1.
  • the above preparation method according to the reaction scheme 1 is performed at reflux temperature using an organic solvent in the presence of a Pd or Cu catalyst, a ligand and a base.
  • the solvent used in the above reaction can be selected from those having high polarity such as ⁇ N'-dimethylformamide, N-methylpyrolidone, pyridine, 1,4- dioxane, C ⁇ -6 alkanol(methanol, ethanol, f-butanol) or a mixture thereof, and preferably N ⁇ N'-dimethylformamide.
  • the catalyst used in the above reaction is a Pd- or Cu-containing compound and is used in the range of about 0.1 to 100 mol% with reference to the amomnt of reactants.
  • the catalyst is selected from the group consisting of Cul, CuCl, and Q12O, and more preferably Cul.
  • the ligand in the above reaction is used in the range of about 0.5 to 3 equivalents with reference to the amount of the catalyst being used.
  • the ligand used is diamines or phosphines, preferably the one selected from the group consisting of N,N'-dimethylethylenediamine, trans-N,N'-l,2-cyclohexanediamine and trans-iV,N'- dimethyl-l,2-cyclohexanediamine, and more preferably JSf,N'- dimethylethylenediamine.
  • the base in the above reaction is used in the range of about 1 to 10 equivalents with reference to the substrate material.
  • the base can be selected from the group consisting of alkali metal alkoxide such as potassium .r-butoxide, potassium methoxide, and sodium methoxide; hydrides such as sodium hydride and potassium hydride; alkali metal carbonate such as potassium carbonate, cesium carbonate, and sodium carbonate; or an alkali metal phosphate such as potassium phosphate and sodium phosphate; and preferably an alkali metal phosphate.
  • alkali metal alkoxide such as potassium .r-butoxide, potassium methoxide, and sodium methoxide
  • hydrides such as sodium hydride and potassium hydride
  • alkali metal carbonate such as potassium carbonate, cesium carbonate, and sodium carbonate
  • an alkali metal phosphate such as potassium phosphate and sodium phosphate
  • an alkali metal phosphate such as potassium phosphate and sodium phosphate
  • the substituted benzopyran compounds of the following formula la, its salts or its solvates are synthesized by reacting a compound of the following formula 2a with a compound of the following formula 3a, its salts or its solvates (e.g., hydrates).
  • the reaction is performed while stirring at about 70 to about 100°C for more than a day using ,N'-dimethylformamide as a solvent in the presence of Cul as a catalyst, N,N'-dimethylethylenedia ine as a ligand, and potassium phosphate as a base.
  • the reactants i.e., the compound of the above formula 2 (especially the compound of the above formula 2a) and the compound of the above formula 3 (especially the compound of the above formula 3a), are novel intermediate compounds used in synthesizing the compound of the above formula 1. Therefore, the compounds of the above formulas 2 and 3 also belong to the scope of the present invention.
  • the compound of the above formula 2 being a novel intermediate compound according to the present invention, can be synthesized by hydrolysis of the compound of the following formula 4 as shown in the following reaction scheme 2.
  • reaction Scheme 2 (4) H ( 2)
  • R 1 , R 2 , A and Y are the same as defined in the above formula 1.
  • an amide group is introduced via hydrolysis using a base in the presence of water, an organic solvent or their mixture. The conditions for a base/ solvent used in the above hydrolysis will be apparent to those skilled in the art.
  • the reaction is performed using a single Ci-6 alkanol solvent such as methanol, ethanol, t-butanol or their mixture as a solvent while using alkali hydroxide such as sodium hydroxide or potassium hydroxide as a base.
  • alkali hydroxide such as sodium hydroxide or potassium hydroxide as a base.
  • the compounds of the following formula 2a, its salts or its solvates are synthesized by reacting the compound of the following formula 4a in the presence of NaOH/f-butanol.
  • the compound of the following formula 3 being a novel intermediate compound of the present invention, can be prepared by (a) synthesizing the compound of the following formula 7 by reacting the compound of the following formula 5 with the compound of the following formula 6, and then (b) performing cyclization reaction of thus obtained compound of the following formula 7, as shown in the following reaction scheme 3.
  • R 3 , R 4 and X are the same as defined in the above formula 1 and Z indicates an activated leaving group.
  • the activated leaving group (Z) of the above reaction scheme 3 are, for example, a halogen atom, an activated amide group represented by - N(R 6 )(OR 6 ) (wherein R 6 is a C ⁇ -6 alkyl group), R 7 0-, R 7 S- or R 7 S0 2 0- (wherein R 7 is a Ci-6 alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl Ci-6 alkyl group), or
  • R 8 is a Ci-6 alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl C 1-6 alkyl group, Y's are independently O or S).
  • the activated leaving group is R 7 0-, wherein R 7 is a Ci- ⁇ alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl Ci-6 alkyl group, more preferably, R 7 is a Ci- ⁇ alkyl group, for example, a methyl group, an ethyl group, z— butyl group or t-butyl group, and most preferably R 7 is an ethyl group.
  • the step (a) of the synthesis according to the above reaction scheme 3 is performed in the presence of N,N'-dimethylformamide, an ether solvent such as tetrahydrofuran; an organic solvent such as toluene, benzene, hexane or a C ⁇ -6 alkanol (e.g., methanol, ethanol, t-butanol); and a base, wherein the base can be selected from the group consisting of alkali metal alkoxide such as potassium t- butoxide, potassium methoxide, and sodium methoxide; hydrides such as sodium hydride; and amides such as potassium amide and sodium amide.
  • an ether solvent such as tetrahydrofuran
  • an organic solvent such as toluene, benzene, hexane or a C ⁇ -6 alkanol (e.g., methanol, ethanol, t-butanol)
  • a base wherein the base
  • the cyclization in step (b) of the synthesis according to the above reaction scheme 3 is performed in the presence of an acid.
  • the cyclization can be performed in the presence of a sulfuric acid using a solvent such as Ci-e alkanol or acetic acid.
  • the cyclization can be performed in the presence of hydrochloric acid in the mixed solvent of Ci-6 alkanol/ tetrahydrofuran.
  • Alternative acid/ solvent conditions will be apparent to those skilled in the art.
  • the reaction can be performed in a suitable solvent such as water or Ci-6 alkanol, unsaturated carbocyclic hydrocarbon such as benzene or toluene, by using an acid such as hydrobromic acid, hydroiodic acid, perchloric acid or p-toluenesulfonic acid; and a Lewis acid such as aluminum trichloride or titanium, tetrachloride.
  • a suitable solvent such as water or Ci-6 alkanol, unsaturated carbocyclic hydrocarbon such as benzene or toluene
  • an acid such as hydrobromic acid, hydroiodic acid, perchloric acid or p-toluenesulfonic acid
  • a Lewis acid such as aluminum trichloride or titanium, tetrachloride.
  • the above reaction is performed in methanol solvent in the presence of sulfuric acid.
  • the compounds of the following formula 3a, its salts or its solvates are prepared by (a) synthesizing the compound of the following formula 7a, its salts and its solvates (e.g., hydrides) by reacting the compound of the following formula 5a with the compound of the following formula 6a, its salts and its solvates (e.g., hydrides) and then (b) performing the cyclization reaction of the compound of the following formula 7a, its salts and its solvates.
  • the compound of the above formula 7 (especially the compound of the above formula 7a) is a novel intermediate compound synthesized during the reaction. Therefore, the compound of the above formula 7 also belongs to the scope of the present invention.
  • the compound of the above formula 7 is indicated as di-keto type in this invention for convenience, but it can be also present in the form of keto-enol and cyclic hydroxy chromanone. Therefore, all of the tautomeric forms of the above formula 7 belong to the scope of this invention.
  • Example 1 Preparation of 4- (4-phenylbutoxy)benzamide To a mixture of 4-(4-phenylbutoxy)benzonitrile (1.9 g, 7.5 mmol) and t- butanol (37 mL) was added NaOH (2.1 g, 38 mmol) and refluxed for 4 hours. The mixture was cooled to room temperature and then added to a mixed solution of water and methanol (4 : 1, 100 mL). The resulting precipitate was filtered, washed with water and then dried under vacuum to give the target compound as a white solid (1.9 g, 94%).
  • the mixture was cooled to room temperature and then slowly added to cold IN HC1 (120 mL).
  • the resulting orange precipitate was filtered, washed with water and then dried under vacuum to obtain the target compound.
  • the target compound was dissolved in ethylacetate by applying heat, added with hexane and then placed at 0 °C for 2 hours.
  • the resulting product was filtered, washed with hexane and then dried under vacuum to give the purified product as a yellow solid(1.7 g, 83%).
  • Example 3 Preparation of 8-iodo-4-oxo-2-tetrazol-5-yl-lH-l-benzopyran
  • the purified product obtained in Example 2(1.5 g, 4.2 mmol) was mixed in methanol(20 mL) and stirred to produce a slurry.
  • the slurry was then added with a cone, sulfuric acid (265 ⁇ L, 5.0 mmol) and refluxed for 7 hours.
  • the mixture was cooled to room temperature and then maintained at 0 °C for an hour.
  • the resulting product was filtered, washed with cold methanol, water and cold methanol.
  • the resulting product was dried under vacuum to afford the target compound as a pale yellow solid(1.3 g, 93%).
  • Example 4 Preparation of 4-oxo-8-[4-(4-ph.enylbutoxy)benzoylamino]-2-tetrazol-5- yl-4H-l-benzopyran Under the nitrogen atmosphere, the purified product obtained in Example 1 (108 mg, 0.40 mmol), the purified product obtained in Example 3 (68 mg, 0.20 mmol), Cul (11.4 mg, 0.04 mmol), potassium phosphate (255 mg, 0.80 mmol) and N,N'- dimemylethylenediamine (13 ⁇ L, 0.08 mmol) were mixed together. The mixture was then added with anhydrous dimethylforrriamide (1 mL) and stirred at 100 °C for two days.
  • the reaction solution was cooled to room temperature and added with water(15 mL).
  • the resulting solution was acidified to pHl-2 by adding a saturated HC1 solution.
  • the precipitated solid was filtered and the resulting solid was suspended in methanol(lOmL) and then filtered to remove the remaining purified product obtained in Example 1.
  • the obtained solid was dissolved in methanol (7mL) by adding sodium acetate (32 mg, 0.40 mmol) and then filtered.
  • the filtrate was added with saturated HC1 solution.
  • the precipitated solid was filtered, washed with cold methanol and then dried under vacuum to obtain the target compound as a pale yellow solid(77 mg, 81%).
  • the present invention relates to a manufacturing process suitable for industrial application, which provides a much improved and more efficient method with secured safety as compared to the conventional methods.
  • the compounds represented in the above formulas 2, 3 and 7 are novel intermediate compounds produced in the course of synthesizing substituted benzopyran compounds of the formula 1, and they will also be very useful in industrial application due to their great stability.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention relates to a novel method of synthesizing substituted benzopyran compounds, their novel intermediates and a method of their preparation thereof.

Description

PROCESS FOR PREPARING SUBSTITUTED BENZOPYRAN COMPOUNDS
Field of Invention The present invention relates to a novel method of preparing substituted benzopyran compounds of the following formula 1, their corresponding novel intermediates and a method of their preparation thereof.
In the above formula 1, R1, R2, R3, R4, A and Yare the same as defined in the detailed description of the invention.
Background of Invention A benzopyran compound is a leukotriene-receptor antagonist already disclosed in EP 0173516 and others, which is also known as a therapeutic agent for treating diseases induced by leukotriene and 5-α-reductase. For example, JP Hei 3- 95144 discloses a method of preparing 3-amino-2-hydroxyacetophenone from the phenol compound of the following formula (A) via a four step process. However, this method is not considered efficient due to its rather long process and also it lacks industrial applicability due to the risk of explosion during a hydrogenation reaction using Pd/C in the reduction step (a) for introducing an amino group. In the above reaction, X indicates a halogen atom. Meanwhile, in USP 5,675,036, and 5,597,929 and W094/124923, their methods of synthesis are not suitable in terms of safety and environmental aspects because not only they employ an acetophenone compound (D) as an intermediate which is rather difficult to be synthesized, but also they use highly explosive and corrosive reagent, SOCl2, for prepariing acyl chloride (E) required for introducing an amide group from amine moiety. Further, the acyl chloride thus produced is in general not very stable and is very difficult to adjust during the commercial
This invention relates to a method of synthesizing a few novel benzopyran compounds disclosed in EP 0173516. The method of the present invention is industrially more applicable since it provides an added safety and efficiency with a fewer number of steps in process as compared to the conventional methods. In particular, the method of this invention follows the convergent pathway, a more efficient process than the conventional linear process. Further, the method of the present invention does not employ a risky process such as hydrogenation reaction and the intermediate materials produced during the reaction are so stable that their separation and purification are quite easy.
Detailed Description of Invention This invention relates to a method of preparing substituted benzopyran compounds having the chemical structure of the following formula 1, a novel intermediate compound used for the process thereof, and a method of preparing the intermediate compound.
In the above formula 1, R1 is selected from the group consisting of a Q-2o alkyl group, a C2-20 alkenyl group, a C2-20 alkynyl group, a phenyl group, a naphthalenyl group and an indanyl group, wherein the groups can be independently substituted by 1 or 2 substituents selected from a Cι-2o alkyl group, a C2-2o alkenyl group and a C2-2o alkynyl group, wherein up to 5 carbon atoms of the substitution groups can be selectively substituted by O, S, N, a halogen atom, a benzene ring, a thiophene ring, a naphthalene ring, a C4-7 carbocyclic ring, a carbonyl group, a carbonyloxy group, a hydroxyl group, a carboxy group, an azido group or a nitro group; R2 and R4 are independently H, a Cι-6 alkyl group, a C2-6 alkenyl group, a C1-6 alkyl group substituted with from 1 to 3 aryl groups, a Cι-6 alkoxycarbonyl group, a Cι-6 alkoxycarbonyl group substituted with an aryl group, an aryloxycarbonyl group, a Cι-6 alkoxy Cι-6 alkyl group, a C3-9 trialkyltin group, a triaryltin group, or a C3-9 trialkylsylyl group, wherein the aryl group or said aryl is a phenyl group substituted with from 1 to 3 substituents which are selected from the group consisting of a phenyl group, a halogen atom, a C1-6 alkyl group and a Cι-6 alkoxy group; R3 is H, a halogen atom, a hydroxy group, a nitro group, a Ci-β alkyl group, a C1-6 alkoxy group, a Cι-6 alkylthio group, or -COOR5 (wherein R5 is H or a Cι-6 alkyl group); A is a single bond; or a C1-10 alkylene group, a C2-10 alkenylene group, or a C2- 10 alkynylene group either substituted or unsubstituted with from 1 to 3 substituents selected from a Cι-10 alkyl group and a phenyl group; X is a halogen atom; and Y is O or S.
In preparing the substituted benzopyran compounds of the above formula 1, R1 is a phenyl group or a substituted phenyl group, wherein the above substituted phenyl group can be substituted with 1 or 2 substituents selected from a C1-20 alkyl group, a C2-20 alkenyl group and a C2-20 alkynyl group, wherein up to 5 carbon atoms of the substitution groups can be selectively substituted by O, S, N, a halogen atom, a benzene ring, a thiophene ring, a naphthalene ring, a C -7 carbocyclic ring, a carbonyl group, a carbonyloxy group, a hydroxyl group, a carboxy group, an azido group or a nitro group. Preferably, R1 is a phenyl group substituted at p-position with a substituent from those exemplified above, and more preferably
In preparing the substituted benzopyran compounds of the above formula 1,
R2 and R4 are independently H, a Ci-6 alkyl group, a C2-6 alkenyl group, a Ci-6 alkyl group substituted with from 1 to 3 aryl groups, or a Ci-6 alkoxycarbonyl group. More preferably, R2 and R4 are independently H. In preparing the substituted benzopyran compounds of the above formula 1, R3 is H. In preparing the substituted benzopyran compounds of the above formula 1,
A is a single bond; or a methylene, ethylene, trimethylene, tetramethylene, vinylene, propenylene, butenylene, butadienylene or ethynylene group either substituted or unsubstituted with from 1 to 3 substituents selected from a Cι-10 alkyl group and a phenyl group. More preferably, A is a single bond.
The substituted benzopyran compounds of the above formula 1 according to the present invention can be prepared by reacting a compound of the following formula 2 with a compound of the following formula 3 as shown in the following reaction scheme 1.
[Reaction Scheme 1] In the above reaction scheme 1, R1, R2, R3, R4, A, X and Y are the same as defined in the above formula 1. The above preparation method according to the reaction scheme 1 is performed at reflux temperature using an organic solvent in the presence of a Pd or Cu catalyst, a ligand and a base. The solvent used in the above reaction can be selected from those having high polarity such as ^N'-dimethylformamide, N-methylpyrolidone, pyridine, 1,4- dioxane, Cι-6 alkanol(methanol, ethanol, f-butanol) or a mixture thereof, and preferably N^N'-dimethylformamide. The catalyst used in the above reaction is a Pd- or Cu-containing compound and is used in the range of about 0.1 to 100 mol% with reference to the amomnt of reactants. Preferably, the catalyst is selected from the group consisting of Cul, CuCl, and Q12O, and more preferably Cul. The ligand in the above reaction is used in the range of about 0.5 to 3 equivalents with reference to the amount of the catalyst being used. The ligand used is diamines or phosphines, preferably the one selected from the group consisting of N,N'-dimethylethylenediamine, trans-N,N'-l,2-cyclohexanediamine and trans-iV,N'- dimethyl-l,2-cyclohexanediamine, and more preferably JSf,N'- dimethylethylenediamine. The base in the above reaction is used in the range of about 1 to 10 equivalents with reference to the substrate material. The base can be selected from the group consisting of alkali metal alkoxide such as potassium .r-butoxide, potassium methoxide, and sodium methoxide; hydrides such as sodium hydride and potassium hydride; alkali metal carbonate such as potassium carbonate, cesium carbonate, and sodium carbonate; or an alkali metal phosphate such as potassium phosphate and sodium phosphate; and preferably an alkali metal phosphate. In a preferred embodiment of the preparation method according to the reaction scheme 1, as shown in the following reaction scheme la, the substituted benzopyran compounds of the following formula la, its salts or its solvates (e.g., hydrates) are synthesized by reacting a compound of the following formula 2a with a compound of the following formula 3a, its salts or its solvates (e.g., hydrates).
[Reaction Scheme la]
In the above reaction scheme la, the reaction is performed while stirring at about 70 to about 100°C for more than a day using ,N'-dimethylformamide as a solvent in the presence of Cul as a catalyst, N,N'-dimethylethylenedia ine as a ligand, and potassium phosphate as a base. Meanwhile, in performing the synthesis according to the above reaction scheme 1, the reactants, i.e., the compound of the above formula 2 (especially the compound of the above formula 2a) and the compound of the above formula 3 (especially the compound of the above formula 3a), are novel intermediate compounds used in synthesizing the compound of the above formula 1. Therefore, the compounds of the above formulas 2 and 3 also belong to the scope of the present invention. The compound of the above formula 2, being a novel intermediate compound according to the present invention, can be synthesized by hydrolysis of the compound of the following formula 4 as shown in the following reaction scheme 2. [Reaction Scheme 2] (4) H ( 2) In the above reaction scheme 2, R1, R2, A and Y are the same as defined in the above formula 1. In the above reaction scheme 2, an amide group is introduced via hydrolysis using a base in the presence of water, an organic solvent or their mixture. The conditions for a base/ solvent used in the above hydrolysis will be apparent to those skilled in the art. For example, the reaction is performed using a single Ci-6 alkanol solvent such as methanol, ethanol, t-butanol or their mixture as a solvent while using alkali hydroxide such as sodium hydroxide or potassium hydroxide as a base. In a preferred embodiment of the preparation method via the hydrolysis according to the reaction scheme 2, as shown in the following reaction scheme 2a, the compounds of the following formula 2a, its salts or its solvates (e.g., hydrates) are synthesized by reacting the compound of the following formula 4a in the presence of NaOH/f-butanol. [Reaction Scheme 2a]
Further, the compound of the following formula 3, being a novel intermediate compound of the present invention, can be prepared by (a) synthesizing the compound of the following formula 7 by reacting the compound of the following formula 5 with the compound of the following formula 6, and then (b) performing cyclization reaction of thus obtained compound of the following formula 7, as shown in the following reaction scheme 3.
[Reaction Scheme 3]
In the above reaction scheme 3, R3, R4 and X are the same as defined in the above formula 1 and Z indicates an activated leaving group. Examples of the activated leaving group (Z) of the above reaction scheme 3 are, for example, a halogen atom, an activated amide group represented by - N(R6)(OR6) (wherein R6 is a Cι-6 alkyl group), R70-, R7S- or R7S020- (wherein R7is a Ci-6 alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl Ci-6 alkyl group), or
(wherein R8 is a Ci-6 alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl C1-6 alkyl group, Y's are independently O or S). . Preferably, the activated leaving group is R70-, wherein R7 is a Ci-β alkyl group, an arbitrarily substituted phenyl group or an arbitrarily substituted phenyl Ci-6 alkyl group, more preferably, R7 is a Ci-β alkyl group, for example, a methyl group, an ethyl group, z— butyl group or t-butyl group, and most preferably R7is an ethyl group. The step (a) of the synthesis according to the above reaction scheme 3 is performed in the presence of N,N'-dimethylformamide, an ether solvent such as tetrahydrofuran; an organic solvent such as toluene, benzene, hexane or a Cι-6 alkanol (e.g., methanol, ethanol, t-butanol); and a base, wherein the base can be selected from the group consisting of alkali metal alkoxide such as potassium t- butoxide, potassium methoxide, and sodium methoxide; hydrides such as sodium hydride; and amides such as potassium amide and sodium amide. The cyclization in step (b) of the synthesis according to the above reaction scheme 3 is performed in the presence of an acid. For example, the cyclization can be performed in the presence of a sulfuric acid using a solvent such as Ci-e alkanol or acetic acid. Further, the cyclization can be performed in the presence of hydrochloric acid in the mixed solvent of Ci-6 alkanol/ tetrahydrofuran. Alternative acid/ solvent conditions will be apparent to those skilled in the art. The reaction can be performed in a suitable solvent such as water or Ci-6 alkanol, unsaturated carbocyclic hydrocarbon such as benzene or toluene, by using an acid such as hydrobromic acid, hydroiodic acid, perchloric acid or p-toluenesulfonic acid; and a Lewis acid such as aluminum trichloride or titanium, tetrachloride. Preferably, the above reaction is performed in methanol solvent in the presence of sulfuric acid. In a preferred embodiment of the preparation method according to the reaction scheme 3, as shown in the following reaction scheme 3a, the compounds of the following formula 3a, its salts or its solvates (e.g., hydrides) are prepared by (a) synthesizing the compound of the following formula 7a, its salts and its solvates (e.g., hydrides) by reacting the compound of the following formula 5a with the compound of the following formula 6a, its salts and its solvates (e.g., hydrides) and then (b) performing the cyclization reaction of the compound of the following formula 7a, its salts and its solvates.
[Reaction Scheme 3a]
Meanwhile, in performing the synthesis according to the above reaction scheme 3, the compound of the above formula 7 (especially the compound of the above formula 7a) is a novel intermediate compound synthesized during the reaction. Therefore, the compound of the above formula 7 also belongs to the scope of the present invention. The compound of the above formula 7 is indicated as di-keto type in this invention for convenience, but it can be also present in the form of keto-enol and cyclic hydroxy chromanone. Therefore, all of the tautomeric forms of the above formula 7 belong to the scope of this invention.
Cyclic hydroxy chromanone
Examples A better understanding of the present invention may be obtained in light of the following examples which are set forth to illustrate, but are not to be construed to limit the present invention.
Example 1: Preparation of 4- (4-phenylbutoxy)benzamide To a mixture of 4-(4-phenylbutoxy)benzonitrile (1.9 g, 7.5 mmol) and t- butanol (37 mL) was added NaOH (2.1 g, 38 mmol) and refluxed for 4 hours. The mixture was cooled to room temperature and then added to a mixed solution of water and methanol (4 : 1, 100 mL). The resulting precipitate was filtered, washed with water and then dried under vacuum to give the target compound as a white solid (1.9 g, 94%).
Η NMR(300MHz, OMSO-dβ) δ 7.81-7.83(m, 3H), 7.15-7.30(m, 6H), 6.95(d, /=9.0Hz, 2H), 4.04(t, /=5.9Hz, 2H), 2.65(t, /=6.9Hz, 2H), 1.73(t, J=3.2Hz, 4H) Example 2: Preparation of 2-iodo-6-[l,3-dioxo-3-(tetrazol-5-yl)propyl]phenol Under the nitrogen atmosphere, anhydrous dimethylformamide (30 mL) was added to a mixture of 2-hydroxy-3-iodoacetophenone (1.5 g, 5.7 mmol), ethyl-lH- tetrazol-5-carboxylate (1.1 g, 7.5 mmol) and potassium f-butoxide (3.2 g, 28.7 mmol) and then stirred at 50 °C for 3 hours. The mixture was cooled to room temperature and then slowly added to cold IN HC1 (120 mL). The resulting orange precipitate was filtered, washed with water and then dried under vacuum to obtain the target compound. The target compound was dissolved in ethylacetate by applying heat, added with hexane and then placed at 0 °C for 2 hours. The resulting product was filtered, washed with hexane and then dried under vacuum to give the purified product as a yellow solid(1.7 g, 83%). ΝMR(300MHz, OMSO-dβ) δ 8.99(br s, 1H), 8.10(dd, ]=7.7, 1.8Hz, 1H), 7.80(dd, 7=8.0, 1.7Hz, 1H), 6.95(t, J=7.8Hz, 1H), 3.57(d, /=16.5Hz, 1H), 3.20(d, /=16.5Hz, 1H)
Example 3: Preparation of 8-iodo-4-oxo-2-tetrazol-5-yl-lH-l-benzopyran The purified product obtained in Example 2(1.5 g, 4.2 mmol) was mixed in methanol(20 mL) and stirred to produce a slurry. The slurry was then added with a cone, sulfuric acid (265 μL, 5.0 mmol) and refluxed for 7 hours. The mixture was cooled to room temperature and then maintained at 0 °C for an hour. The resulting product was filtered, washed with cold methanol, water and cold methanol. The resulting product was dried under vacuum to afford the target compound as a pale yellow solid(1.3 g, 93%). Η NMR(300MHz, DMSO- ) δ8.35(dd, 1=7.7, 1.7Hz, 1H), 8.07(dd J=7.8, 1.5Hz, 1H), 7.33(t, /=8.0, 1H), 7.11(s, 1H)
Example 4: Preparation of 4-oxo-8-[4-(4-ph.enylbutoxy)benzoylamino]-2-tetrazol-5- yl-4H-l-benzopyran Under the nitrogen atmosphere, the purified product obtained in Example 1 (108 mg, 0.40 mmol), the purified product obtained in Example 3 (68 mg, 0.20 mmol), Cul (11.4 mg, 0.04 mmol), potassium phosphate (255 mg, 0.80 mmol) and N,N'- dimemylethylenediamine (13 μL, 0.08 mmol) were mixed together. The mixture was then added with anhydrous dimethylforrriamide (1 mL) and stirred at 100 °C for two days. The reaction solution was cooled to room temperature and added with water(15 mL). The resulting solution was acidified to pHl-2 by adding a saturated HC1 solution. The precipitated solid was filtered and the resulting solid was suspended in methanol(lOmL) and then filtered to remove the remaining purified product obtained in Example 1. The obtained solid was dissolved in methanol (7mL) by adding sodium acetate (32 mg, 0.40 mmol) and then filtered. The filtrate was added with saturated HC1 solution. The precipitated solid was filtered, washed with cold methanol and then dried under vacuum to obtain the target compound as a pale yellow solid(77 mg, 81%).
Industrial Applicability As stated above, the present invention relates to a manufacturing process suitable for industrial application, which provides a much improved and more efficient method with secured safety as compared to the conventional methods. In particular, the compounds represented in the above formulas 2, 3 and 7 are novel intermediate compounds produced in the course of synthesizing substituted benzopyran compounds of the formula 1, and they will also be very useful in industrial application due to their great stability.
The invention has been described in detail with reference to preferred embodiments thereof. However, it will be appreciated that those skilled in the art, upon consideration of the disclosure, may make modifications and improvements within the scope and spirit of the invention.

Claims

Claims
1. A compound of the following formula 1, its salts or its solvates, prepared by reacting a compound of the following formula 2 with a compound of the following formula 3,
wherein R1 is selected from the group consisting of a C1-20 alkyl group, a C2-20 alkenyl group, a C2-2o alkynyl group, a phenyl group, a naphthyl group and an indanyl group, wherein said groups can be independently substituted by 1 or 2 substituents selected from a Q-2o alkyl group, a C2-20 alkenyl group and a C2-20 alkynyl group, wherein up to 5 carbon atoms of said substitution groups can be optionally substituted by O, S, N, a halogen atom, a benzene ring, a thiophene ring, a naphthalene ring, a C -7 carbocyclic ring, a carbonyl group, a carbonyloxy group, a hydroxy group, a carboxy. group, an azido group or a nitro group; R2and R4 are independently H, a Ci-6 alkyl group, a C2-6 alkenyl group, a Ci-6 alkyl group substituted with from 1 to 3 aryl groups, a Cι-6 alkoxycarbonyl group, a Ci-6 alkoxycarbonyl group substituted with an aryl group, an aryloxycarbonyl group, a Ci-6 alkoxy Ci-6 alkyl group, a Q3-9 trialkyltin group, a triaryltin group, or a C3-9 trialkylsilyl group, wherein said aryl group or said aryl is a phenyl group substituted with from 1 to 3 substituents which are selected from the group consisting of a phenyl group, a halogen atom, a Cι-6 alkyl group and a C1-6 alkoxy group; R3 is H, a halogen atom, a hydroxy group, a nitro group, a Ci-6 alkyl group, a Ci-6 alkoxy group, a Cι-6 alkylthio group, or -COOR5 (wherein R5 is H or a Cι-6 alkyl group); A is a single bond; or a O-io alkylene group, a C2-10 alkenylene group, or a C2- io alkynylene group either substituted or unsubstituted with from 1 to 3 substituents selected from a Ci-io alkyl group and a phenyl group; X is a halogen atom; and Y is O or S.
independently H,
A is a single bond, X is I, Br or Cl; Y is O.
3. In claim 1, said reaction is performed in the presence of a palladium- or copper- containing compound as a catalyst, diamine as a ligand and a base.
4. In claim 3, said reaction is performed in the presence of a catalyst selected from the group consisting of Cul, CuCl, and Q12O; a ligand selected from the group consisting of N,N'-dimethylethylenediamine, trans-N,N'-l,2-cyclohexanediamine and trans-N,N'-dimethyl-l,2-cyclohexanediamine; and a base selected from the group consisting of cesium carbonate and potassium phosphate.
5. In claim 4, said reaction is performed in the presence of Cul as a catalyst, N,N*- dimethylethyleneamine as a ligand, and potassium phosphate as a base.
6. In any one of claims 3, 4 and 5, said reaction is performed by using dimethylf ormamide as a solvent.
7. In claim 1, the compound of formula la, its salts and its solvates are prepared by reacting a compound of the formula 2a with a compound of the following formula 3a, its salts or its solvates
8. In claim 7, said reaction is performed at about 70 to 100 °C in the presence of N,N'- dimethylformamide as a solvent, Cul as a catalyst, N,N'-dimethylethyleneamine as a ligand, and potassium phosphate as a base.
9. An intermediate compound represented by the following formula 2, its salts or its solvates,
H (2) wherein R1, R2, A and Y are the same as defined in claim 1.
10. In claim 9, said intermediate compound represented by the above formula 2 is 4- (4-pheny lbutoxy )benzamide .
11. An intermediate compound represented by the following formula 3, its salts or its solvates,
wherein R3, R4 and X are the same as defined in claim 1.
12. In claim 11, said intermediate compound represented by the above formula 3 is 8-iodo -4-oxo -2-tetrazol -5-yl -1H-1 -benzopyran.
13. A method of preparing a compound of the following formula 3 comprising: (a) preparing a compound of the following formula 7 by reacting a compound of the following formula 5 and a compound of the following formula 6; and (b) performing a cyclization of the compound obtained in (a), wherein R3, R4 and X are the same as defined in claim 1, and Z indicates an activated leaving group.
14. In claim 13, said cyclization is performed by using methanol as a solvent in the presence of sulfuric acid.
15. In claim 13, a compound of the following formula 3a, its salts or its solvates are prepared by: (a) preparing a compound of the following formula 7a by reacting a compound of the following formula 5a and a compound of the following formula 6a, its salts or its solvates; and, (b) performing a cyclization of the compound obtained in (a).
16. An intermediate compound represented by the following formula 7, its salts or its solvates, wherein R3, R4 and X are the same as defined in claim 1.
17. In claim 16, said intermediate compound represented by the above formula 7 is 2-iodo-6-[l,3-dioxo-3-(tetrazol-5-yl)propyl]phenol.
EP05726439A 2004-02-12 2005-02-07 Process for preparing substituted benzopyran compounds Withdrawn EP1713796A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020040009280A KR100683274B1 (en) 2004-02-12 2004-02-12 Process for preparing substituted benzopyran compound
PCT/KR2005/000365 WO2005077942A1 (en) 2004-02-12 2005-02-07 Process for preparing substituted benzopyran compounds

Publications (2)

Publication Number Publication Date
EP1713796A1 true EP1713796A1 (en) 2006-10-25
EP1713796A4 EP1713796A4 (en) 2009-11-25

Family

ID=34858705

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05726439A Withdrawn EP1713796A4 (en) 2004-02-12 2005-02-07 Process for preparing substituted benzopyran compounds

Country Status (5)

Country Link
EP (1) EP1713796A4 (en)
JP (1) JP4512100B2 (en)
KR (1) KR100683274B1 (en)
CN (1) CN1918150B (en)
WO (1) WO2005077942A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2758016A1 (en) 2008-06-05 2009-12-10 Novotyr Therapeutics Ltd. Novel modulators of protein kinase signaling
EP3021944B1 (en) 2013-07-14 2018-12-19 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Igf-1r signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
CN107250108B (en) 2015-02-05 2020-11-27 特尔诺沃有限公司 Combination of IRS/STAT3 dual modulator and anticancer agent for the treatment of cancer

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US389339A (en) * 1888-09-11 Friction-clutch
CA960223A (en) * 1970-02-05 1974-12-31 Mervyn E. Peel Tetrazolyl chromones
GB1296469A (en) 1970-02-05 1972-11-15
US4238495A (en) * 1976-01-30 1980-12-09 Miles Laboratories, Inc. 1-(4-Cyano-phenoxy)-2-hydroxy-3-[2-(5-1H-tetrazolyl)-chromon-5-yloxy]-propane and salts thereof
US4158663A (en) * 1977-07-15 1979-06-19 Warner-Lambert Company Process for the production of 2-substituted chromones
JPS60246384A (en) * 1984-05-21 1985-12-06 Hokuriku Seiyaku Co Ltd Chromone-8-carboxamide derivative
CA1261835A (en) * 1984-08-20 1989-09-26 Masaaki Toda (fused) benz(thio)amides
EP0340706B1 (en) * 1988-05-03 1993-10-13 BASF Aktiengesellschaft Process for the preparation of carboxylic-acid chlorides
JPH0395144A (en) * 1989-08-04 1991-04-19 Ono Pharmaceut Co Ltd Production of aminophenol derivative
JPH051008A (en) * 1991-06-19 1993-01-08 Mitsubishi Kasei Corp Production of 1,4-dicyanobutene compounds
GB9224922D0 (en) 1992-11-27 1993-01-13 Smithkline Beecham Plc Process
ATE259799T1 (en) 1994-06-23 2004-03-15 Sumitomo Chemical Co METHOD FOR PRODUCING 2-(TETRAZOLE-5-YL)-4-OXO-4H-BENZOPYRANES
CH691301A5 (en) * 1995-06-29 2001-06-29 Sumitomo Chemical Co A process for preparing 2-acetyl-6- (4- (4-phenylbutoxy) benzoyl) aminophenol.
AR004029A1 (en) * 1995-10-20 1998-09-30 Smithkline Beecham Plc NEW PHARMACEUTICAL FORMULATIONS
JPH09323955A (en) * 1996-06-03 1997-12-16 Kao Corp Benzoic acid derivative and medicament containing the same
DE69721775T2 (en) * 1996-07-01 2004-01-29 Du Pont NICKEL-CATALYZED ADDITION OF -NH- CONTAINING COMPOUNDS ON VINYL AND ARYL HALOGENIDES
GB9700331D0 (en) 1997-01-09 1997-02-26 Smithkline Beecham Plc Process
SK285410B6 (en) * 1997-05-09 2007-01-04 H. Lundbeck A/S A process of manufacturing sertindole and its intermediates
AU2003256970A1 (en) * 2002-08-02 2004-02-23 Rhodia Pharma Solutions Inc. Copper catalyzed arylation

Also Published As

Publication number Publication date
WO2005077942A1 (en) 2005-08-25
CN1918150B (en) 2010-05-05
JP4512100B2 (en) 2010-07-28
KR100683274B1 (en) 2007-02-15
CN1918150A (en) 2007-02-21
KR20050081042A (en) 2005-08-18
JP2007522206A (en) 2007-08-09
EP1713796A4 (en) 2009-11-25

Similar Documents

Publication Publication Date Title
JP5817079B2 (en) Process for preparing 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof
JP2003508387A (en) Bicyclic androgen and progesterone receptor modulator compounds and methods
JP3763828B2 (en) Process for producing intermediates for precursor synthesis of benzopyran compounds
KR20110083870A (en) Method for preparing tetrazole methanesulfonic acid salts and novel compounds used therein
WO2005070909A1 (en) An improved process for the preparation of gefitinib
WO2005077942A1 (en) Process for preparing substituted benzopyran compounds
CN100410255C (en) Inosine and its production method
CN114230526B (en) A kind of synthetic method of 4-3 (H) quinazolinone and derivative thereof
KR100760015B1 (en) Intermediates for the synthesis of benzopyran compounds
KR100716274B1 (en) Compound for Synthesizing Substituted Benzopyran Compound
US5440036A (en) 1,4-benzoxazine derivatives
KR100740325B1 (en) Compound for Synthesizing Substituted Benzopyran Compound
US6114549A (en) Process of making 3-phenyl-1-methylenedioxyphenyl-indane-2-carboxylic acid derivatives
WO2006132424A1 (en) Process for production of 4(3h)-quinazolinone derivative
JP4607917B2 (en) Process for producing 8-amino-4-oxo-2- (tetrazol-5-yl) -4H-1-benzopyran or a salt thereof, and intermediate for production thereof
EP4182294A1 (en) Method and intermediate compounds for the preparation of menaquinone mk-7
CN105712939B (en) A kind of method of synthesizing rosuvastatin spit of fland calcium key intermediate
JP5432910B2 (en) High purity synthetic process for the preparation of dodecahydro-naphtho-furanyl-carbamic acid ester intermediate
JP2002338570A (en) Method for producing 3-amino-1,8-naphthyridin-2 (1H) -one derivative
KR20050036409A (en) A process for preparing carbazolone derivatives
JPH0782267A (en) 1,4-benzoxazine derivative
HK1231871A1 (en) A process for the preparation of compound and synthetic intermediates thereof
JPH10330367A (en) Production of quionazoline compound
KR20080113160A (en) 8-Amino-4-oxo-2- (tetrazol-5-yl) -4H-1-benzopyran and a process for producing franukast through it
HK1167136B (en) A process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060825

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): IT TR

DAX Request for extension of the european patent (deleted)
RBV Designated contracting states (corrected)

Designated state(s): IT TR

A4 Supplementary search report drawn up and despatched

Effective date: 20091028

17Q First examination report despatched

Effective date: 20100420

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20121127